These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two support the notion of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-relevant Diseases. These outcomes counsel that conolidine is https://davea966ggg6.bimmwiki.com/user